Pulmonx Corporation
LUNG
$1.33
-$0.05-3.29%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 6.80% | 4.24% | 0.62% | 1.60% | 2.79% |
| Total Depreciation and Amortization | -38.12% | -29.40% | -19.41% | -18.23% | 0.98% |
| Total Amortization of Deferred Charges | 454.72% | 1.92% | -68.18% | -17.86% | -134.42% |
| Total Other Non-Cash Items | -12.19% | -10.27% | -8.74% | -12.71% | -1.54% |
| Change in Net Operating Assets | 168.93% | -13.04% | 118.70% | 131.47% | 59.57% |
| Cash from Operations | 11.26% | -2.66% | 3.71% | 10.21% | 10.33% |
| Capital Expenditure | 87.66% | 68.76% | 64.19% | 45.60% | -8.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -61.91% | 63.47% | 1,959.91% | 1,342.97% | 1,066.15% |
| Cash from Investing | -60.99% | 74.42% | 6,713.76% | 933.70% | 813.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -38,952.63% | -5.26% | -5.38% | -4.30% | -1.06% |
| Issuance of Common Stock | -53.90% | -31.21% | -28.56% | -17.14% | -23.20% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 88.74% | -38.88% | -36.27% | -21.82% | -24.68% |
| Foreign Exchange rate Adjustments | -12.99% | -221.05% | 57.19% | -10,133.33% | -226.23% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -393.87% | 90.87% | 141.88% | 131.32% | 110.98% |